IP Library Patent Application 11850032
Patent Application
App. No. 11/850,032

POST-BIOPSY CAVITY TREATMENT IMPLANTS AND METHODS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/850,032
Abstract

A method for mapping a lymphatic system following a cavity generating procedure, may include a step of providing a post-biopsy cavity treatment implant, the implant including a collagenous matrix having a non-uniform cross-linking density that is configured to cause the implant to swell non-uniformly when placed within an aqueous environment, the implant including a dye or a pigment contained therein. The provided post-biopsy cavity treatment implant may then be implanted into the cavity and the cavity closed. The dye/pigment may then be caused to be released from the implant and to propagate through the lymphatic system. The propagated dye/pigment may then be visualized in the lymphatic system using a selected visualization mode.

Claims (11)

1 . A method for mapping a lymphatic system following a cavity generating procedure, comprising:

providing a post-biopsy cavity treatment implant, the implant including a collagenous matrix having a non-uniform cross-linking density that is configured to cause the implant to swell non-uniformly when placed within an aqueous environment, the implant including a dye or a pigment contained therein;

implanting the provided post-biopsy cavity treatment implant into the cavity;

closing the cavity with the post-biopsy cavity treatment implant implanted therein;

causing the dye/pigment to be released from the implant and to propagate through the lymphatic system, and

visualizing the propagated dye/pigment in the lymphatic system using a selected visualization mode.

2 . The method of claim 1 , wherein the implant in the providing step includes a reservoir disposed within the collagenous matrix, the reservoir containing a volume of the dye/pigment and wherein the causing step includes a step of rupturing the reservoir to release the dye/pigment.

3 . The method of claim 2 , wherein the rupturing step includes a step of squeezing the implanted post-biopsy cavity treatment implant.

4 . The method of claim 1 , wherein the causing step includes a step of waiting for a predetermined period of time during which the implant degrades within the cavity and releases the dye/pigment.

5 . The method of claim 1 , wherein the at least one of dye and pigment is loaded within the collagenous matrix of the implant.

6 . The method of claim 1 , wherein visualizing mode in the visualizing step includes at least one of ultrasound, x-ray, magnetic resonance imaging, elastography, microwave and the unaided eye.

Assignments (3)
MERGER Recorded Jan 21, 2013
From: RUBICOR MEDICAL, LLC
To: ENCAPSULE MEDICAL, LLC
Reel/Frame 029663/0773 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 10, 2010
From: RM LIQUIDATING F/K/A RUBICOR MEDICAL, INC.
To: RUBICOR MEDICAL, LLC
Reel/Frame 024358/0197 →
SECURITY AGREEMENT Recorded Apr 23, 2008
From: RUBICOR MEDICAL, INC.
To: HOLOGIC, INC.
Reel/Frame 020845/0034 →